Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 160,323 | 159,554 | 114,362 | 131,762 | 127,224 |
| Operating Income | -160,323 | -159,554 | -114,362 | -131,762 | -127,224 |
| Other Income | 7,099 | 8,854 | 5,279 | 5,854 | 7,524 |
| Pre-tax Income | -153,224 | -150,700 | -109,083 | -125,908 | -119,700 |
| Income Tax | N/A | -2,844 | 1,552 | 594 | 913 |
| Net Income Continuous | -153,224 | -147,856 | -110,635 | -126,502 | -120,613 |
| Net Income | $-153,224 | $-147,856 | $-110,635 | $-126,502 | $-120,613 |
| EPS Basic Total Ops | -0.75 | -0.72 | -0.61 | -0.73 | -0.71 |
| EPS Basic Continuous Ops | -0.75 | -0.73 | -0.61 | -0.73 | -0.71 |
| EPS Diluted Total Ops | -0.75 | -0.72 | -0.61 | -0.73 | -0.71 |
| EPS Diluted Continuous Ops | -0.75 | -0.73 | -0.61 | -0.73 | -0.71 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.73 | -0.61 | -0.73 | -0.60 |
| EBITDA(a) | $-160,231 | $-159,458 | $-114,261 | $-131,657 | $-127,117 |